{
    "2018-04-30": [
        [
            {
                "time": "2018-01-03",
                "original_text": "Dividend Aristocrats That Also Offer Stock Price Growth",
                "features": {
                    "keywords": [
                        "Dividend",
                        "Aristocrats",
                        "Stock Price Growth"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "finance"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-01-04",
                "original_text": "Exxon Mobil Corporation Leads 6 Dividend Stocks Boosting Payouts",
                "features": {
                    "keywords": [
                        "Exxon",
                        "Mobil",
                        "Dividend",
                        "Payouts"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "energy"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-05",
                "original_text": "3 Top Value Stocks to Buy Right Now",
                "features": {
                    "keywords": [
                        "Top",
                        "Value",
                        "Stocks",
                        "Buy"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "general"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-01-06",
                "original_text": "Johnson & Johnson Facing 3 Important Risks in Coming Year",
                "features": {
                    "keywords": [
                        "Johnson",
                        "&",
                        "Johnson",
                        "Risks"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-01-07",
                "original_text": "Ramp Up In Opdivo And Eliquis Sales Bolsters Bristol-Myers Squibb's Q1 Earnings",
                "features": {
                    "keywords": [
                        "Opdivo",
                        "Eliquis",
                        "Sales",
                        "Bristol-Myers Squibb",
                        "Q1 Earnings"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-08",
                "original_text": "Why Analysts Expect Pfizer to See Revenue Growth in 1Q18",
                "features": {
                    "keywords": [
                        "Analysts",
                        "Expect",
                        "Pfizer",
                        "Revenue Growth",
                        "1Q18"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-09",
                "original_text": "Is Fidelity Dividend ETF for Rising Rates (FDRR) a Hot ETF Right Now?",
                "features": {
                    "keywords": [
                        "Fidelity",
                        "Dividend",
                        "ETF",
                        "Rising Rates",
                        "FDRR"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "finance"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-01-10",
                "original_text": "What Analysts Expect for Pfizer in 1Q18",
                "features": {
                    "keywords": [
                        "Analysts",
                        "Expect",
                        "Pfizer",
                        "1Q18"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-11",
                "original_text": "Eliquis and Xeljanz: Key Growth Drivers for Pfizer in 2018",
                "features": {
                    "keywords": [
                        "Eliquis",
                        "Xeljanz",
                        "Growth Drivers",
                        "Pfizer",
                        "2018"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-12",
                "original_text": "Cytori Updates On US Manufacturing And EU Approval Plans For ATI-0918",
                "features": {
                    "keywords": [
                        "Cytori",
                        "US Manufacturing",
                        "EU Approval",
                        "ATI-0918"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "biotechnology"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}